Editorial Policies

Focus and Scope

Eksergi, a broad-based open access journal, printed ISSN 1410-394 X, wishes to invite scientists and researchers working in the field of Engineering to submit their research articles for publication consideration in any of the topics listed below:


- Separation in Chemical Engineering
- Energy and related to Renewable or Sustainable energy
- Process and Production of Chemical Engineering
- Nanomaterial particle
- Chemical engineering design and process control
- Carbon capture utilization and storage
- Waste and wastewater treatment
- Bioprocess related to food security, fine chemicals, and renewable energy
- Life Cycle Assessment

Eksergi publishes high-quality solicited and unsolicited articles, in Bahasa Indonesia or in English, in all areas of Chemical Engineering sciences and related disciplines. The journals welcome the submission of manuscripts that meet the general criteria of significance and scientific excellence. Papers will be published shortly after acceptance.

All articles published by Eksergi are peer-reviewed. 

The following types of papers are considered for publication:

•        Original articles in basic and applied research

•        Case studies

•        Critical reviews, surveys, opinions, commentaries and essays.

It is recommended that English check of the manuscript by competent and knowledgable native speaker, before completed submission. Only manuscripts that are writted in clear and concise English will be accepted for peer reveiwing process. All languague in English must be well spelling in American or British. It is higly recommended to check standard scientific usage and symbol in the manuscript.

 

 

 

Section Policies

Artikel

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Eksergi (ISSN 1410-394 X) is published by Department of Chemical Engineering, Faculty of Industrial Engineering, Universitas Pembangunan Nasional "Veteran" Yogyakarta.  Accepted manuscript will be published via online in this website. Since 2022, Eksergi published the articles in three issues a year.

This open access journal is free of charge. Only selected manuscript will be reviewed by two or three peer reviewers. The manuscript should not yet published in other journal, contain high originality, and not meets conflict of interest and fraud.

All of the manuscript will be screened by software plagiarism such as Turnitin, Mendeley or Google Scholar. However the accepatance will be decided by Chief Editor or Editorial Board.

 

 

 

Publication Frequency

Since 2022, Eksergi published three issues a year: March, July, November. 

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

All articles published Open Access will be immediately and permanently free for everyone to read and download.  We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows:
• Creative Commons Attribution Non- Commercial Share Alike (CC-NC BY SA)

 

Editing Process

All of authors should check the manuscript for plagiarism content. However Editor will double check the manuscript for plagiarism (for example using Mendeley Software plagiarism checker). The manuscript will be rejected if it contains plagiarism such not complete references, similar paragraph but no source authors.

 

Plagiarism Screening

Eksergi uses Turnitin as plagiarism checker to all submitted papers. The submitted manuscript will be rejected if the plagiarism index in the manuscript is more than 20%.

 

 

Article Processing Charge

Submission manuscript in Eksergi is free of charge.

Handling fee for accepted manuscript is Rp.500.000/manuscript.

However it is mandatory for all selected manuscript to proofread their English grammar in a third party proofread agency.

 

 

Advertising Policy

  1. All advertisements and commercially sponsored publications are independent from editorial decisions. The Editorial board does not endorse any product or service marked as an advertisement or promoted by a sponsor in EKSERGI publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
  2. The EKSERGI management reserves the right to decline any type of advertising that is damaging to the brand of EKSERGI journal or is inappropriate to the content held on the journal.
  3. The EKSERGI journal will not accept advertising for products or services known to be harmful to health (e.g. tobacco and alcohol products).
  4. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  5. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher request its removal.
  6. The EKSERGI journal will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) or on any page where content relates to the product(s) being advertised. (Advertisers may not link to articles using keywords; they may not target advertising for a specific product on the condition that it appear in the same location and at the same time as a specific article mentioning that product and they may not refer to an article published at the same time as the advertisement appears).
  7. Advertisements and editorial content must be clearly distinguishable. The journal will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  8. Editorial decisions will not be influenced by current or potential sponsors and advertisers, and will not be influenced by marketing decisions. Advertisers and sponsors have no control or influence over the results of searches a user may conduct on the website by keyword or search topic.
  9. If any advert is requested outside of journal standard advertising positions then a request should be made to editorial who will respond with a full and final decision within three business days.
  10. Information about complaints concerning advertisements will be included in the Advertisements page.
  11. We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you. 

Advertising complaints policy

Please send any complaints about advertising to: editor.eksergi@gmail.com

 

Informed Consent Policy and Archiving

The Journal’s policy for informed object consent for case reports and similar article follows the publication ethics set out by the Committee on Publication Ethics (COPE) and EKSERGI recommendations.  Written descriptions, photographs and pedigrees that lead to subject identification should be avoided unless the information is essential for scientific purposes and the objects or legal guardian has given written informed consent for publication. Identifying details should be omitted unless it is necessary.  However, the object data should never be altered or falsified to attain anonymity.  A statement addressing informed object consent must be included as a part of the manuscript.


Vision Journal has electronic backup and preservation of access to the content of its journals via PKP Preservation Network (PKP PN). This can be seen at Publisher Manifest.

PKP has developed the PKP Preservation Network (PKP PN) to digitally preserve OJS journals. The LOCKSS program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content. The PKP PN ensures that journals that are not part of any other digital preservation service (such as CLOCKSS or Portico) can be preserved for long-term access. For additional details about the PKP PN, Please kindly see the high-level overview (an early discussion document).

 

Retraction Handling

General Principles

EKSERGI believes in protecting and maintaining the integrity of the academic record. Articles officially published in this journal are considered as the “Version of Record”. Very rarely, when the scientific information in an article is substantially undermined then it becomes necessary for EKSERGI to publish corrections to, or retractions of articles published in its journal, at the discretion of the editors.

 

Article Corrections

Authors are encouraged to report errors in their articles with regard to the accuracy of published information. Only errors that impact the article significantly will be considered. Corrections are made at the journal’s discretion. The correction procedure depends on the publication stage of the article. Corrections will be published under corrections and addendum in a later issue of the journal.

 

Article Retractions

The article may be retracted because of scientific misconduct in cases such as multiple submissions, bogus claims of authorship, plagiarism or fraudulent use of data. A signed statement from the concerned authors will be required to be submitted before an article can be retracted. Agreement of all authors of a paper is required before a retraction can be published. A notice of retraction will be published and linked to the original article clearly marked as a retracted. The notice will also include the reason for the retraction and who is retracting the article. The original article will not be removed from online or print versions of the journal, but will be identified as a retracted article. Retractions will also be listed on the contents page.

 

Article Withdrawal

Articles can be withdrawn either by the authors or the publisher. Article withdrawal by authors may be permitted only for the most compelling and unavoidable reasons, after submitting a letter signed by all authors of the article to the editorial office stating the reason for article withdrawal. Authors must not assume that their article has been withdrawn until they have received appropriate notification to this effect from the editorial office. If an article is found to violate the ethical publishing guidelines of EKSERGI such as duplicate publication, plagiarism, fraudulent use of data, multiple submission or bogus claims of authorship, the publisher has all the rights to withdraw that article.

 

Guidelines for Using Generative AI in Manuscript Preparation

Authors submitting manuscripts to Eksergi are permitted to use Generative Artificial Intelligence (Gen-AI) tools for specific purposes, such as translation and language polishing. Gen-AI tools can assist in translating manuscripts into English or other languages to enhance readability and in refining language for clarity, grammatical accuracy, and adherence to academic writing standards.

However, authors remain fully responsible for the accuracy, scientific integrity, and originality of their manuscripts. The use of Gen-AI must not result in plagiarism or ethical violations. Authors are required to thoroughly review and verify all content generated or polished by Gen-AI tools to ensure compliance with Eksergi's ethical standards and submission requirements.

If Gen-AI tools are utilized, authors must acknowledge their use in the manuscript, specifying the purpose, in the author statement (e.g., "This manuscript has benefited from language editing and polishing using [Tool Name]"). This acknowledgment ensures transparency while maintaining the accountability of the author for the final content.

By submitting a manuscript, authors agree that they have adhered to these guidelines and take full responsibility for any issues arising from the use of Gen-AI tools during manuscript preparation.